Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,610 | 36,356 | 8,988 | 2,568 | 3,394 |
| Marketable Securities | 107,556 | 41,112 | 11,587 | 7,271 | 8,690 |
| TOTAL | $144,258 | $78,731 | $21,851 | $11,525 | $14,264 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 210 | 240 | 270 | 314 | 57 |
| TOTAL | $210 | $240 | $270 | $314 | $57 |
| Total Assets | $144,468 | $78,971 | $22,121 | $11,839 | $14,321 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,721 | 3,451 | 3,180 | 3,050 |
| Accounts payable and accrued liabilities | 1,493 | 658 | 1,529 | 1,556 | 1,305 |
| Accrued Expenses | N/A | 34 | 22 | 10 | 59 |
| Other current liabilities | N/A | 37 | 1,398 | 2,030 | 894 |
| TOTAL | $4,105 | $6,339 | $8,657 | $9,614 | $7,727 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $6 |
| Total Liabilities | $4,105 | $6,339 | $8,657 | $9,614 | $7,733 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,658 | 50,933 | 50,899 | 28,499 | 27,697 |
| Common Shares | 1 | 1 | N/A | 0 | 0 |
| Retained earnings | -91,078 | -84,406 | -80,855 | -76,771 | -70,671 |
| Other shareholders' equity | -147 | -109 | -20 | -4 | -6 |
| TOTAL | $140,363 | $72,632 | $13,464 | $2,226 | $6,588 |
| Total Liabilities And Equity | $144,468 | $78,971 | $22,121 | $11,840 | $14,321 |